| Literature DB >> 36043069 |
Jiaxing Zhang1,2, Hui Hui3, Wei Xu1, Kai Hua1, Yali Cui1, Xiaonan Liu1.
Abstract
Genetic variation plays a crucial role in disease occurrence and development. However, current genotyping strategies not only require a long turnaround time for DNA purification, but also depend on sophisticated apparatus and complex data interpretation, which seriously limits their application in point of care diagnostic test scenarios. In this study, by integrating phosphate induced coloration reaction and loop-mediated isothermal amplification, a rapid and portable strategy for straightforward genotyping has been established to cater to the demand of precision medicine. By employing phosphate ions produced during the amplification as a signal generator, not only can the genotyping result be interpreted with only naked eye from a low-cost label-free strip, but also the amplification efficiency is increased to facilitate genotyping with a robust biological specimen ignoring DNA polymerase inhibitors. Moreover, the introduction of alkaline lysis for DNA release allows whole blood to be identified accurately avoiding DNA purification. As a proof of concept, the insertion/deletion polymorphisms of the angiotensin-converting enzyme, a crucial factor associated with cardiovascular and cerebrovascular diseases, has been selected as a model to evaluate the performance of this method. Accurate results can be obtained from as low as 1 ng genomic DNA within 30 min. For clinical specimen detection, a concordance rate up to 100% has been found compared with PCR-based electrophoresis. Thus, this novel strategy may serve as a promising tool for straightforward genotyping to provide timely diagnostic information, especially in resource-poor medical institutions. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 36043069 PMCID: PMC9364437 DOI: 10.1039/d2ra03989c
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Schematic diagram of visual genotyping system.
Fig. 2The signal intensity of negative (weak than colorimetric standard of 25 mg L−1) and positive (strong than colorimetric standard of 25 mg L−1) result observed by naked eyes taking the standard colorimetric card as a reference.
Fig. 3ACE indels identification results. Identification results with genomic DNA provided by (A) phosphate induced coloration reaction, (B) LAMP-based electrophoresis and (C) PCR-based electrophoresis.
Comparison of general parameters and properties (characteristics and analytical performances) between the developed genotyping strategies and the LAMP phosphate induced coloration reactiona,b,c
| Conventional PCR[ | HRM[ | Real-time PCR[ | PCR-LFA[ | T-ARMS-PCR-LFA[ | LAMP phosphate induced coloration reaction | |
|---|---|---|---|---|---|---|
| Template | DNA | DNA | DNA | DNA/blood | DNA/blood | DNA/blood |
| Probes | None | None | None | None | None | None |
| Labels | None | None | None | Antibody/hapten | Antibody/hapten | None |
| DNA extraction | √ | √ | √ | √/× | √/× | √/× |
| Product detection | Agarose gel electrophoresis | Melting curve | Fluorescence | LFA | LFA | Phosphate induced coloration reaction |
| Total analysis time (min) | ∼160 | ∼145 | ∼130 | ∼135/∼80 | ∼135/∼80 | ∼85/∼30 |
| POCT | × | × | × | √ | √ | √ |
Note: T-ARMS-PCR: tetra-primer amplification-refractory-mutation-system PCR.
√ means DNA extraction is included, and × means DNA extraction is not included.
√ means the genotyping strategy is applicable for the POCT scenario, and × means the genotyping strategy is unamiable for POCT scenario and result detection requires interpretation by a professional.
Fig. 4Direct genotyping result provided by phosphate induced coloration reaction. (A) The response signal with different ratios of whole blood to alkaline polyethylene glycol for blood lysis. (B) ACE indels identification results from whole blood directly.
Identification results of ACE indels provided by phosphate induced coloration reaction
| Genotyping with genomic DNA | Genotyping from whole blood directly | Total | Discrepant | Agreement | ||
|---|---|---|---|---|---|---|
| II | ID | DD | ||||
| II | 10 | 0 | 0 | 10 | 0 | 100% |
| ID | 0 | 10 | 0 | 10 | 0 | 100% |
| DD | 0 | 0 | 5 | 5 | 0 | 100% |
| Total | 10 | 10 | 5 | 25 | 0 | 100% |